National Emerging Infectious Diseases Laboratories
![](http://upload.wikimedia.org/wikipedia/commons/thumb/9/90/National_Emerging_Infectious_Diseases_Laboratories_Building.jpg/220px-National_Emerging_Infectious_Diseases_Laboratories_Building.jpg)
The National Emerging Infectious Diseases Laboratories (NEIDL), is a biosciences facility of Boston University located on Albany street, within the clinical and biopharma hub of the South End neighborhood of Boston, Massachusetts.
The lab is part of a national network of secure facilities that study infectious diseases, whether naturally occurring or introduced through bioterrorism. The Labs include a BSL-4 laboratory, which study the most dangerous and deadly human diseases.[citation needed]
The NEIDL's current director is Dr. Nancy Sullivan, ScD, who previously served at the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). [1]
History
On February 2, 2006, Boston Medical Center received regulatory approval from the federal government to fund construction of a biosafety laboratory on its medical campus in the South End, Boston.[citation needed]
There has been strong community opposition to the planned building, and BSL-2 level research did not begin until 2012 due to court injunctions.[2]
In early 2014, BSL-4 research was still being opposed by community groups including the Union Park Neighborhood Association and Boston City Councilor Charles Yancey who was conducting hearings on its safety and recommending a citywide ban on BSL-4 research.[citation needed]
The NEIDL was given final approval for BSL-4 research by the Boston Public Health Commission on December 6, 2017, with the support of Boston Mayor Marty Walsh. Every project at the lab will also need individual BPHC review and approval.[3]
Current research
As a result of the COVID-19 pandemic, the NEIDL paused research outside of SARS-CoV-2 diagnositics and countermeasures to respond to the COVID-19 pandemic. [4]
See also
- Galveston National Laboratory (GNL)
- National Institute of Allergy and Infectious Diseases (NIAID)
- Rocky Mountain Laboratories (RML)
References
- ^ Thurston, Andrew. "Nancy J. Sullivan, Ebola Vaccine and Treatment Pioneer, Named New NEIDL Director". The Brink.
- ^ "BU Questions Claims Behind Ordinance to Ban BSL-4 Research: City Council Hearing on April 16", BU Press Release, March 17th, 2014
- ^ "Research on the world's deadliest microbes will soon begin at a Boston lab - The Boston Globe". BostonGlobe.com.
- ^ Moran, Barbara (25 March 2020). "Scientists In Boston Drop Ebola Research, For Now, To Focus on Coronavirus". WBUR.
External links
- Boston University National Emerging Infectious Diseases Laboratories
- v
- t
- e
- 75 State Street
- 100 Federal Street
- 100 Summer Street
- 111 Huntington Avenue
- 125 High Street
- 145 High Street
- 200 Clarendon Street (John Hancock Tower)
- 28 State Street
- 33 Arch Street
- 500 Boylston Street
- 60 State Street
- Ames Building
- Avalon North Station
- Berkeley Building
- Boston City Hall
- Custom House Tower
- Exchange Place
- Federal Reserve Bank Building
- Four Seasons Hotel & Private Residences, One Dalton Street
- Harbor Towers I
- Harbor Towers II
- Keystone Building
- Landmark Center
- Liberty Hotel (Charles Street Jail)
- Liberty Mutual Tower
- Massachusetts Eye and Ear Infirmary
- McCormack Building
- Millennium Place Tower I
- Millennium Place Tower II
- Millennium Tower
- National Emerging Infectious Diseases Laboratories
- Omni Parker House
- One Beacon Street
- One Boston Place
- One Devonshire Place
- One Federal Street
- One Financial Center
- One International Place
- One Lincoln Street
- One Post Office Square
- Pierce Boston
- Prudential Tower
- Radian Boston
- Rowes Wharf
- Russia Wharf
- Saltonstall Building
- State Street Bank Building
- Two International Place
- United Shoe Machinery Corporation Building
- 111 Federal Street
- North Station (original)
42°20′10″N 71°04′07″W / 42.336016°N 71.068593°W / 42.336016; -71.068593